Sécurité sanitaire et qualité des aliments
 

Edition en ligne: "Résidus pour les médicaments vétérinaires"

Aide en ligne   Terminology

Cette base de données contient l'information la plus récente sur les niveaux de résidus maximum pour les médicaments vétérinaires recommandés par JECFA. Toute la documentation publiée dans l'étude FAO Alimentation et Nutrition No. 41 est disponible en ligne en format numérique. Cette documentation existe seulement en Anglais, tandis que les pages d'information générale et une partie de la base de données sont traduites en Anglais, Français, Espagnol, Arabe et Chinois.

Médicament vétérinaire Eprinomectin
Classe fonctionnelle Antiparasitic
Dernière évaluation 1998
Réunion de JECFA 50
DJA 0-10 µg/kg bw
Statut de la DJA Full
Monographies des résidus  
Définition du résidu Eprinomectin B1a
Limites maximales de résidu
(LMR) recommandés
CattleFat250 µg/kgF
CattleKidney300 µg/kgF
CattleLiver2000 µg/kgF
CattleMilk20 µg/lF
CattleMuscle100 µg/kgF
Autres remarques
Résumé de l'évaluation In recommending MRLs for various tissue matrices, the Committee took the following factors into consideration:
- The drug is for use in dairy and beef cattle.
- The limits of quantification of the analytical methods are 1.0 µg/l and 2.0 µg/kg for milk and tissues, respectively.
- The marker residue is eprinomectin B1a.
- The marker residue is always the predominant residue in both tissues and milk. Eprinomectin B1a accounted for 69% of the total residues in muscle and 83% of those in liver and pid=63155; the corresponding values for kidney, fat and milk were 85%, 92% and 77%,respectively.
- The completeness of the total data set provided by the sponsorallowed values for MRLs in cows to be derived statistically.
In recommending MRLs for eprinomectin, the Committee took into account the proportion of the total residues in all tissues over the total withdrawal times reported by the sponsor.
The values for the proportion of the total residues accounted for by the marker residue used to set MRLs for eprinomectin in non-ruminating calves were those established in radiometric studies in cattle. The Committee concluded that the extent of metabolism of eprinomectin in calf tissues would probably be less than or equal to the extent of metabolism of the drug in the same tissues in cattle.
From these MRLs, the theoretical maximum daily intake of eprinomectin residues would be 356 µg.
TRS 888